Best Hodgkin's lymphoma hematologist-oncologists in Barcelona: TOP 4 doctors

Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.

He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.

He received his Doctor of Medicine degree from the University of Barcelona in 2002.

Dr. Kobo continues his research and has been awarded grants:

•Interdepartmental Commission for Innovation of the Generalitat de Catalunya

•Scholarship Fund Universitaria Agustí Pedro i Pons

•Farreras Valentí & Schering Plough School of Hematology Scholarship

•Award for the best report at the Council of the Spanish Hematology Association

•Grant from the Catalan Society of Hematology

Specialization:

•Lymphoma

•Acute leukemia

•Chronic leukemia

•Autoimmune pancytopenia

• Dr. Isabel Badell Serra specializes in Hodgkin's lymphoma treatment, focusing on pediatric cases.
• She utilizes chemotherapy, radiation therapy, immunotherapy, and bone marrow transplantation to provide comprehensive care.
• She has international experience practicing at clinics in Spain, the United States, and Germany.
• She is the head of the Center of Bone Marrow Transplantation, leading advancements in treatment protocols.
• She is a member of the European Society for Pediatric Hematology/Oncology (ESPHO) and the American Society of Hematology (ASH).

• Expert in Hodgkin's lymphoma treatment, specializing in chemotherapy, radiation therapy, and stem cell transplantation.
• The doctor has experience of international practice at medical institutions in Spain, the United States, and the United Kingdom.
• Member of the European Hematology Association, promoting excellence in patient care and research.
• Fluent in Spanish and English, adept at communicating with patients from various backgrounds.
• Renowned for her expertise in pediatric hematology and bone marrow transplantation.

Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.